Clinical trials
Recruiting Hyperlipoproteinemia Type II trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Verve Therapeutics, Inc. | 2 |
| Arrowhead Pharmaceuticals | 1 |
| Atlantic Health System | 1 |
| Brigham and Women's Hospital | 1 |
| University of Maryland, Baltimore | 1 |
| University of Wisconsin, Madison | 1 |
| Vanderbilt University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 11 |
| Homozygous Familial Hypercholesterolemia | 4 |
| Hypercholesterolemia | 4 |
| Hyperlipidemias | 4 |
| Dyslipidemias | 3 |
| Aortic Valve Stenosis | 2 |
| Cardiovascular Diseases | 2 |
| Heart Failure | 2 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.